Yunjin Zang

1.0k total citations
50 papers, 760 citations indexed

About

Yunjin Zang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yunjin Zang has authored 50 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Yunjin Zang's work include Ferroptosis and cancer prognosis (10 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (7 papers). Yunjin Zang is often cited by papers focused on Ferroptosis and cancer prognosis (10 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (7 papers). Yunjin Zang collaborates with scholars based in China, Sweden and Madagascar. Yunjin Zang's co-authors include Liqun Wu, Junyu Huo, Dexi Chen, Likun Zhuang, Xiang Ma, Zusen Wang, Zehua Wu, Chao Yang, Ying Shi and Lijuan Zhang and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Journal of Hepatology.

In The Last Decade

Yunjin Zang

50 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunjin Zang China 18 405 298 189 147 123 50 760
Xuanfu Xu China 14 470 1.2× 243 0.8× 76 0.4× 186 1.3× 159 1.3× 25 820
Juji Dai China 11 388 1.0× 241 0.8× 205 1.1× 123 0.8× 74 0.6× 19 665
Alvin Wei Tian Ng Singapore 10 429 1.1× 330 1.1× 102 0.5× 160 1.1× 131 1.1× 15 1.0k
Runchen Miao China 21 689 1.7× 602 2.0× 170 0.9× 184 1.3× 187 1.5× 37 1.1k
Jieting Tang China 14 556 1.4× 405 1.4× 70 0.4× 175 1.2× 142 1.2× 31 966
Chao Wu China 15 423 1.0× 263 0.9× 116 0.6× 193 1.3× 88 0.7× 62 768
Wuxuan Mei China 9 425 1.0× 220 0.7× 135 0.7× 193 1.3× 70 0.6× 16 735

Countries citing papers authored by Yunjin Zang

Since Specialization
Citations

This map shows the geographic impact of Yunjin Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunjin Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunjin Zang more than expected).

Fields of papers citing papers by Yunjin Zang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunjin Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunjin Zang. The network helps show where Yunjin Zang may publish in the future.

Co-authorship network of co-authors of Yunjin Zang

This figure shows the co-authorship network connecting the top 25 collaborators of Yunjin Zang. A scholar is included among the top collaborators of Yunjin Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunjin Zang. Yunjin Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huo, Junyu, Liqun Wu, & Yunjin Zang. (2021). Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer. Journal of Immunology Research. 2021. 1–24. 11 indexed citations
3.
4.
5.
Huo, Junyu, Liqun Wu, & Yunjin Zang. (2021). Eight-gene prognostic signature associated with hypoxia and ferroptosis for gastric cancer with general applicability. Epigenomics. 13(11). 875–890. 19 indexed citations
6.
Wang, Shuo, Tao Liu, Xuan Qiu, et al.. (2021). Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. HepatoBiliary Surgery and Nutrition. 10(2). 172–179. 27 indexed citations
7.
Wang, Shuxian, Bo He, Huan Liu, et al.. (2021). Immunotherapeutic strategy based on anti-OX40L and low dose of IL-2 to prolong graft survival in sensitized mice by inducing the generation of CD4+ and CD8+ Tregs. International Immunopharmacology. 97. 107663–107663. 4 indexed citations
8.
Xu, Shifeng, Yuan Guo, Yanwu Zeng, et al.. (2021). Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma. BMC Cancer. 21(1). 152–152. 12 indexed citations
9.
10.
Xu, Shifeng, Yuan Guo, Xin Zhang, et al.. (2020). Somatic Mutation Profiling of Intrahepatic Cholangiocarcinoma: Comparison between Primary and Metastasis Tumor Tissues. Journal of Oncology. 2020. 1–10. 8 indexed citations
11.
Liang, Jie, Li‐Zhen Zhao, Xiangyan Zhang, et al.. (2020). NLRP3 inflammasome is involved in nerve recovery after sciatic nerve injury. International Immunopharmacology. 84. 106492–106492. 23 indexed citations
12.
Huo, Junyu, Liqun Wu, & Yunjin Zang. (2020). A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma. Frontiers in Molecular Biosciences. 7. 581354–581354. 29 indexed citations
13.
Huo, Junyu, Liqun Wu, & Yunjin Zang. (2020). Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 25(2). 1151–1165. 42 indexed citations
14.
Xu, Qingguo, Shengxian Yuan, Qi-fei Tao, et al.. (2019). A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma. Journal of Hepatology. 70(5). 904–917. 20 indexed citations
15.
Sanjiv, Kumar, Helge Gad, Therese Pham, et al.. (2019). Karonudib is a promising anticancer therapy in hepatocellular carcinoma. Therapeutic Advances in Medical Oncology. 11. 3862482000–3862482000. 22 indexed citations
16.
Guo, Zhihua, Yunjin Zang, & Lijuan Zhang. (2019). The efficacy of Polyporus Umbellatus polysaccharide in treating hepatitis B in China. Progress in molecular biology and translational science. 163. 329–360. 20 indexed citations
17.
Pang, Lijun, Kai Liu, Daojie Liu, et al.. (2018). Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease. Cell Death and Disease. 9(2). 90–90. 46 indexed citations
18.
Dong, Sheng, Xiang Ma, Zusen Wang, et al.. (2017). YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor. Oncotarget. 8(25). 40583–40593. 19 indexed citations
19.
20.
Liu, Kai, Tao Jiang, Yabo Ouyang, et al.. (2015). Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma. Oncotarget. 6(18). 16507–16516. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuanfu Xu Breakdown of academic impact, for papers by Juji Dai Breakdown of academic impact, for papers by Alvin Wei Tian Ng Breakdown of academic impact, for papers by Runchen Miao Breakdown of academic impact, for papers by Jieting Tang Breakdown of academic impact, for papers by Chao Wu Breakdown of academic impact, for papers by Wuxuan Mei
Rankless by CCL
2026